Media Release on Unaudited Financial Results for the quarter ended 30th June, 2026
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 29 Jul 2026, 02:27 PM IST · BSE ID: 1f284b06-02aa-4833-921d-feda6c90cd74
View Original BSE Filing (PDF)
💡
In Simple Terms
The company increased its sales and operating profit in the latest quarter, but net profit declined due to a comparison with a prior period's currency gains.
🤖 AI Summary
- Consolidated revenue for Q1 FY27 increased 9% year-on-year to Rs. 1,074 crores.
- EBITDA grew 25% year-on-year to Rs. 178 crores, with EBITDA margin at 16.6%.
- Profit After Tax for Q1 FY27 was Rs. 88 crores, a 38% year-on-year decrease.
- The company maintains a debt-free status with Rs. 767 crores in cash and liquid investments.
- Product registrations totaled 3,016, with an additional 1,027 applications in the pipeline.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue
Rs. 1,074 crores
9%
Gross Profit
Rs. 394 crores
13%
Gross Profit Margin
36.7%
120 bps
EBITDA
Rs. 178 crores
25%
EBITDA Margin
16.6%
220 bps
Profit Before Tax*
Rs. 118 crores
(30%)
Profit After Tax*
Rs. 88 crores
(38%)
Cash, Bank and Liquid Investments
Rs. 767 crores
🏢 How This Affects the Company
Consolidated revenue growth of 9% indicates continued business expansion, driven by strong performance in NAFTA and LATAM regions for the agrochemical segment, offsetting an 11% decline in Europe.
Gross Profit Margin expanded by 120 basis points to 36.7% and EBITDA Margin improved by 220 basis points to 16.6%, reflecting enhanced operational profitability. Despite this, Profit After Tax declined by 38% due to a high base from forex gains in the prior year.
The increase in product registrations to 3,016 and 1,027 pending applications indicates ongoing investment in product development and market access, supporting future revenue streams.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results disclosure.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reported by the 9% year-on-year consolidated revenue growth and 38% decrease in Profit After Tax.
🔍
Management Signal
Management is focused on maintaining operational profitability and growth in key regions like NAFTA and LATAM, while addressing temporary moderation in Europe and continuing investment in product registrations.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor European market recovery and overall revenue growth.
Update on product registrations pipeline — check conversion into commercial products.
Capex deployment — assess impact of Rs. 263 crores spent in Q1 FY27.
LOW RISK
Financial results show overall growth in revenue and EBITDA, with a debt-free position providing stability.
💡 Investor Takeaway
Sharda Cropchem's Q1 FY27 consolidated revenue increased 9% to Rs. 1,074 crores. EBITDA grew 25% to Rs. 178 crores, improving margins. Profit After Tax decreased 38% to Rs. 88 crores, attributed to higher Q1 FY26 forex gains. Company remains debt-free with Rs. 767 crores in cash and liquid investments.
⚖️ Strengths & Concerns
✅ Positives
- EBITDA growth of 25% year-on-year to Rs. 178 crores, accompanied by a 220 bps expansion in EBITDA Margin to 16.6%.
- Company remains debt-free with Rs. 767 crores in cash, bank, and liquid investments, providing financial flexibility.
⚠️ Concerns
- Profit After Tax decreased 38% year-on-year to Rs. 88 crores, primarily due to higher forex gains in Q1 FY26.
- Agrochemical revenue from Europe declined by 11% year-on-year to Rs. 467 crores due to reduced restocking by distributors.
📅 Company Track Record
Sharda Cropchem's Q1 FY27 standalone revenue from operations was Rs. 28,577.50 lakh. In FY26, the company's PAT doubled to Rs. 681 crores, with revenue increasing 22%. The Board approved FY26 results and recommended a Rs. 9.00 per share final dividend.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Sharda Cropchem's consolidated revenue for Q1 FY27?
Sharda Cropchem's consolidated revenue for the quarter ended June 30, 2026, was Rs. 1,074 crores, representing a 9% year-on-year increase.
What was Sharda Cropchem's EBITDA for Q1 FY27?
The company reported an EBITDA of Rs. 178 crores for Q1 FY27, which is a 25% increase year-on-year, with an EBITDA Margin of 16.6%.
Why did Sharda Cropchem's Profit After Tax decrease in Q1 FY27?
Sharda Cropchem's Profit After Tax decreased 38% to Rs. 88 crores in Q1 FY27 primarily because Q1 FY26 had higher forex gains, creating a high base for comparison.
What is Sharda Cropchem's cash and liquid investments position as of June 30, 2026?
As of June 30, 2026, Sharda Cropchem reported being debt-free with cash, bank, and liquid investments totaling Rs. 767 crores.
Which regions showed significant revenue growth for Sharda Cropchem's agrochemical business in Q1 FY27?
In Q1 FY27, the agrochemical business saw significant revenue growth in NAFTA (33% to Rs. 339 crores) and LATAM (52% to Rs. 72 crores), while Europe declined by 11% to Rs. 467 crores.
Questions based on this BSE filing only. For information purposes.